Skip to content
value.today

EIP Pharma, Inc.

Total raised
$37 M
4 rounds on record
Latest round
$5 M
Dec 2020
First round on record
Apr 2018
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of EIP Pharma, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2020$5 MNo. 4$2 to $10 million

EIP Pharma, Inc.: Raise no. 4, Dec 2020

Investors in this round

28 investors had bought by the notice of Jan 15, 2021: 28 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $10 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Alam · Executive Officer, Director
  • Noel Donnelly · Executive Officer
  • Frank Zavrl · Director
  • Jeff Poulton · Director
  • Sylvie Gregoire · Director
  • Tatjana May · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Noel Donnelly, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 15, 2021. Read the notice at the SEC.

debt, optionsSEC
Jan 2020$3 MNo. 3$2 to $10 million

EIP Pharma, Inc.: Raise no. 3, Jan 2020

Investors in this round

6 investors had bought by the notice of Jan 23, 2020: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $5 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Alam · Executive Officer, Director
  • Noel Donnelly · Executive Officer
  • Sylvie Gregoire · Executive Officer, Director
  • Frank Zavrl · Director
  • Jeff Poulton · Director
  • Tatjana May · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Noel Donnelly, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 23, 2020. Read the notice at the SEC.

equitySEC
Dec 2018$9 MNo. 2$2 to $10 million

EIP Pharma, Inc.: Raise no. 2, Dec 2018

Investors in this round

4 investors had bought by the notice of Dec 19, 2018: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $13 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Alam · Executive Officer, Director
  • Sylvie Gregoire · Executive Officer, Director
  • Frank Zavrl · Director
  • Jeff Poulton · Director
  • Tatjana May · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by John Alam, President. Source: SEC Form D, newest notice filed Dec 19, 2018. Read the notice at the SEC.

equitySEC
Apr 2018$21 MNo. 1$10 to $50 million

EIP Pharma, Inc.: Raise no. 1, Apr 2018

Investors in this round

3 investors had bought by the notice of Apr 13, 2018: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$21 M of $21 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Alam · Executive Officer, Director
  • Sylvie Gregoire · Executive Officer, Director
  • Tatjana May · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by John Alan, President. Source: SEC Form D, newest notice filed Apr 13, 2018. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • EIP Pharma, Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2021).

    SEC Form D · Jan 2021

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jan 2021

That is all the official record says: EIP Pharma, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of EIP Pharma, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 28 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by EIP Pharma, Inc.
NameRoleNamed in
John AlamExecutive officerJan 2021
Noel DonnellyExecutive officerJan 2021
Sylvie GregoireExecutive officerJan 2020
Frank ZavrlDirectorJan 2021
Jeff PoultonDirectorJan 2021
John AlamDirectorJan 2021
Sylvie GregoireDirectorJan 2021
Tatjana MayDirectorJan 2021